Literature DB >> 21768270

Immunohistochemical characterization of macrophages and myofibroblasts in α-Naphthylisothiocyanate (ANIT)--induced bile duct injury and subsequent fibrogenesis in rats.

Hossain M Golbar1, Takeshi Izawa, Ryo Yano, Chisa Ichikawa, Osamu Sawamoto, Mitsuru Kuwamura, Jonathan Lamarre, Jyoji Yamate.   

Abstract

To investigate pathogenesis of post-bile duct (BD) injury fibrosis, interlobular BD epithelial injury was induced in male F344 rats by a single IP injection of α-naphthylisothiocyanate (75 mg/kg body weight) and rats were observed for 12 days. On days 1 to 2, cholangiocytes were injured and desquamated. On days 3 to 5, the affected BD began to regenerate, showing positive staining for CK19 and vimentin. On days 5 to 9, fibrotic areas gradually developed around regenerating BD in Glisson's sheath. These consisted of cells positive for vimentin, desmin, and α-SMA; vimentin- and desmin-positive cells were increased in early stage (days 1-3), whereas α-SMA-positive cells appeared in mid (days 4-7) and late stages (days 8-12), although there were cells coexpressing these cytoskeletons. On day 12, BD regeneration almost completed, with reduced fibrosis. Macrophages positive for ED2 (CD163) increased transiently in early stage, whereas those reacting to ED1 (CD68), OX6 (MHC II), and SRA-E5 (CD204) showed a consistent increase throughout the experiment. Interestingly, OX6-positive cells were limited to Glisson's sheath, whereas SRA-E5-positive cells were seen exclusively along sinusoids of hepatic lobules. MCP-1 mRNA increased significantly in early stage. This study shows that macrophages exhibiting different immunophenotypes and distributions participate in post-BD injury fibrosis associated with myofibroblasts expressing various mesenchymal cytoskeletons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768270     DOI: 10.1177/0192623311413790

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  7 in total

1.  Effects of human amnion-derived mesenchymal stem cells and conditioned medium in rats with sclerosing cholangitis.

Authors:  Ryo Sugiura; Shunsuke Ohnishi; Masatsugu Ohara; Marin Ishikawa; Shuichi Miyamoto; Reizo Onishi; Koji Yamamoto; Kazumichi Kawakubo; Masaki Kuwatani; Naoya Sakamoto
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 2.  Histopathological Analysis of Rat Hepatotoxicity Based on Macrophage Functions: in Particular, an Analysis for Thioacetamide-induced Hepatic Lesions.

Authors:  Jyoji Yamate; Takeshi Izawa; Mitsuru Kuwamura
Journal:  Food Saf (Tokyo)       Date:  2016-09-17

3.  Recovery of the Cholangiocytes After Ischemia and Reperfusion Injury: Ultra-Structural, Hystological and Molecular Assessment in Rats.

Authors:  Thiago P A Aloia; Bruno Cogliati; Janaina M Monteiro; Anna C K Goldberg; Paolo R de Oliveira Salvalaggio
Journal:  J Clin Exp Hepatol       Date:  2018-02-11

4.  Dynamic expression of desmin, α-SMA and TGF-β1 during hepatic fibrogenesis induced by selective bile duct ligation in young rats.

Authors:  J O Gonçalves; A C A Tannuri; M C M Coelho; I Bendit; U Tannuri
Journal:  Braz J Med Biol Res       Date:  2014-08-15       Impact factor: 2.590

5.  Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice.

Authors:  Romina Fiorotto; Aileen Raizner; Carola M Morell; Barbara Torsello; Roberto Scirpo; Luca Fabris; Carlo Spirli; Mario Strazzabosco
Journal:  J Hepatol       Date:  2013-03-07       Impact factor: 25.083

6.  Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis.

Authors:  Feng Jin; Du Cheng; Jun-Yan Tao; Shu-Ling Zhang; Ran Pang; Yuan-Jin Guo; Pian Ye; Ji-Hua Dong; Lei Zhao
Journal:  BMC Gastroenterol       Date:  2013-05-03       Impact factor: 3.067

7.  Kupffer Cells: Important Participant of Hepatic Alveolar Echinococcosis.

Authors:  Yumei Liu; Fengming Tian; Jiaoyu Shan; Jian Gao; Bin Li; Jie Lv; Xuan Zhou; Xuanlin Cai; Hao Wen; Xiumin Ma
Journal:  Front Cell Infect Microbiol       Date:  2020-01-29       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.